Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
HY-13433 |
Thapsigargin |
|
99.95% |
Unkown |
HY-18723 |
Yoda 1 |
|
99.98% |
Unkown |
HY-100545 |
BAPTA-AM |
Inhibitor |
99.68% |
Unkown |
HY-W009724 |
2-Aminoethyl diphenylborinate |
|
99.86% |
Unkown |
HY-D0861 |
EGTA |
|
≥98.0% |
Unkown |
HY-101896 |
Fluo-4 AM |
|
≥99.0% |
Unkown |
HY-N0219 |
Bicuculline |
Antagonist |
99.97% |
Unkown |
HY-19608 |
GSK1016790A |
|
99.79% |
Unkown |
HY-D0989 |
Rhod-2 AM |
|
≥97.0% |
Unkown |
HY-100202 |
TPEN |
|
99.69% |
Unkown |
HY-P2149 |
Concanavalin A |
Inducer |
/ |
Unkown |
HY-100168 |
BAPTA |
Inhibitor |
98.10% |
Unkown |
HY-126010 |
Dooku1 |
Antagonist |
99.89% |
Unkown |
HY-10588 |
Bay K 8644 |
Agonist |
99.96% |
Unkown |
HY-118630 |
Vacuolin-1 |
Inhibitor |
98.93% |
Unkown |
HY-100831 |
YM-58483 |
Inhibitor |
99.38% |
Unkown |
HY-12323 |
ISX-9 |
Activator |
98.90% |
Unkown |
HY-101455 |
CDN1163 |
Activator |
99.89% |
Unkown |
HY-138620 |
MCU-i4 |
Inhibitor |
99.87% |
Unkown |
HY-15754 |
CGP37157 |
Inhibitor |
99.50% |
Unkown |
HY-131614 |
TPC2-A1-N |
Inhibitor |
99.86% |
Unkown |
HY-100001 |
SKF-96365 hydrochloride |
|
99.91% |
Unkown |
HY-100912 |
W-7 hydrochloride |
|
99.96% |
Unkown |
HY-101379A |
8-Bromo-cGMP sodium |
Inhibitor |
99.07% |
Unkown |
HY-113308A |
Taurolithocholic acid sodium salt |
Agonist |
99.81% |
Unkown |
HY-119287 |
TSQ |
|
99.88% |
Unkown |
HY-N6732 |
K-252a |
Inhibitor |
99.45% |
Unkown |
HY-120691A |
GSK205 |
Antagonist |
99.91% |
Unkown |
HY-103312 |
Xestospongin C |
Inhibitor |
≥90.0% |
Unkown |
HY-103319 |
Calmidazolium chloride |
Antagonist |
99.69% |
Unkown |
HY-19805 |
STO-609 |
Inhibitor |
98.13% |
Unkown |
HY-123071A |
Box5 TFA |
Antagonist |
94.71% |
Unkown |
HY-P0256 |
Apamin |
Inhibitor |
99.85% |
Unkown |
HY-108465 |
Pyr3 |
Inhibitor |
99.90% |
Unkown |
HY-116522 |
AR420626 |
|
98.29% |
Unkown |
HY-15415 |
KB-R7943 mesylate |
Inhibitor |
99.16% |
Unkown |
HY-101897 |
Fura-2 AM |
|
≥99.0% |
Unkown |
HY-108599 |
DCP-LA |
|
≥98.0% |
Unkown |
HY-D1498 |
Mag-Fluo-4 AM |
|
≥96.0% |
Unkown |
HY-D1024 |
Coelenterazine h |
|
98.02% |
Unkown |
HY-N6778 |
Paxilline |
Inhibitor |
99.83% |
Unkown |
HY-12949 |
ML204 |
Inhibitor |
99.08% |
Unkown |
HY-D0716 |
Fluo-3AM |
|
≥99.0% |
Unkown |
HY-15124 |
(S)-(-)-Bay-K-8644 |
Agonist |
98.81% |
Unkown |
HY-116330A |
Hyperforin dicyclohexylammonium salt |
|
99.52% |
Unkown |
HY-116429 |
Maresin 1 |
Inhibitor |
99.00% |
Unkown |
HY-15515 |
SEA0400 |
Inhibitor |
99.96% |
Unkown |
HY-N0043 |
Ginsenoside Rd |
Inhibitor |
99.88% |
Unkown |
HY-D0973 |
EGTA-AM |
|
≥90.0% |
Unkown |
HY-101906 |
DC260126 |
|
99.74% |
Unkown |
HY-N6789 |
KT5720 |
Inhibitor |
≥99.0% |
Unkown |
HY-101017 |
Palmitoylcarnitine chloride |
|
≥98.0% |
Unkown |
HY-135897 |
Urolithin C |
|
≥98.0% |
Unkown |
HY-P3278A |
Caloxin 2A1 TFA |
Inhibitor |
99.96% |
Unkown |
HY-19408 |
Pyr10 |
Inhibitor |
99.42% |
Unkown |
HY-119401 |
CAY10444 |
Antagonist |
≥98.0% |
Unkown |
HY-107543 |
8-CPT-2Me-cAMP sodium |
Activator |
99.58% |
Unkown |
HY-110105 |
NS8593 hydrochloride |
Inhibitor |
99.81% |
Unkown |
HY-16697 |
CID 16020046 |
Antagonist |
99.87% |
Unkown |
HY-101044 |
PPADS tetrasodium |
|
≥95.0% |
Unkown |
HY-120261 |
GB-88 |
Inhibitor |
99.05% |
Unkown |
HY-N0252 |
Catharanthine |
Inhibitor |
99.65% |
Unkown |
HY-120528A |
GB-110 hydrochloride |
Agonist |
99.86% |
Unkown |
HY-133168 |
Englerin A |
Activator |
99.50% |
Unkown |
HY-107411 |
Bromoenol lactone |
Inhibitor |
98.41% |
Unkown |
HY-111208 |
CCT129957 |
Inhibitor |
99.71% |
Unkown |
HY-107658 |
SN 6 |
Inhibitor |
99.79% |
Unkown |
HY-126750 |
GNF362 |
Inhibitor |
99.63% |
Unkown |
HY-15416 |
NS309 |
Activator |
99.09% |
Unkown |
HY-103309 |
ML218 |
Inhibitor |
99.49% |
Unkown |
HY-103307 |
FPL64176 |
Agonist |
99.81% |
Unkown |
HY-12496 |
NS-1619 |
|
98.06% |
Unkown |
HY-14229 |
TGR5 Receptor Agonist |
Agonist |
99.71% |
Unkown |
HY-124171 |
Zinquin ethyl ester |
|
≥99.0% |
Unkown |
HY-100168B |
BAPTA tetrapotassium |
Inhibitor |
99.45% |
Unkown |
HY-P1345A |
TLQP-21 TFA |
Agonist |
99.90% |
Unkown |
HY-Y0413 |
Biacetyl monoxime |
Inhibitor |
≥98.0% |
Unkown |
HY-103306 |
Ryanodine |
|
99.35% |
Unkown |
HY-N0515 |
Ophiopogonin D |
|
99.54% |
Unkown |
HY-160187 |
AAA |
|
98.10% |
Unkown |
HY-103320A |
Calhex 231 hydrochloride |
Inhibitor |
99.81% |
Unkown |
HY-N2549 |
(±)-Abscisic acid |
Inducer |
99.91% |
Unkown |
HY-114252 |
Strophanthidin |
Inhibitor |
92.66% |
Unkown |
HY-101360 |
1-EBIO |
Agonist |
99.96% |
Unkown |
HY-N0607 |
Ginsenoside Ro |
|
99.81% |
Unkown |
HY-10171 |
NPS-2143 hydrochloride |
Antagonist |
99.80% |
Unkown |
HY-103474 |
Bicuculline methiodide |
Inhibitor |
99.24% |
Unkown |
HY-110153 |
NS19504 |
Activator |
99.93% |
Unkown |
HY-D1903 |
Fura Red AM |
|
91.00% |
Unkown |
HY-N0601 |
Ginsenoside Rf |
Inhibitor |
99.48% |
Unkown |
HY-157131 |
TRPV2-selective blocker 1 |
Inhibitor |
99.84% |
Unkown |
HY-N0084 |
Betulinaldehyde |
Inhibitor |
98.72% |
Unkown |
HY-16992A |
W-54011 |
|
≥98.0% |
Unkown |
HY-103660 |
18:0 LYSO-PE |
|
≥99.0% |
Unkown |
HY-123071 |
Box5 |
Antagonist |
98.32% |
Unkown |
HY-124873 |
SERCA2a activator 1 |
Activator |
99.54% |
Unkown |
HY-W018035 |
DL-Glyceric Acid |
|
≥97.0% |
Unkown |
HY-14350 |
AC-55541 |
Agonist |
99.25% |
Unkown |
HY-15671 |
GKA50 |
Activator |
99.57% |
Unkown |
HY-N2344 |
Procyanidin A1 |
Inhibitor |
99.19% |
Unkown |
HY-P1080A |
ω-Agatoxin IVA TFA |
Inhibitor |
98.13% |
Unkown |
HY-124416 |
ML604086 |
Inhibitor |
99.80% |
Unkown |
HY-145542 |
Isovalerylcarnitine chloride |
Activator |
≥98.0% |
Unkown |
HY-16689 |
VU 0240551 |
Inhibitor |
99.97% |
Unkown |
HY-16690 |
BTS |
Inhibitor |
99.74% |
Unkown |
HY-N4104 |
Agaric acid |
Activator |
99.57% |
Unkown |
HY-P1821A |
Myelin Basic Protein TFA |
|
97.35% |
Unkown |
HY-100168A |
BAPTA tetrasodium |
Inhibitor |
99.70% |
Unkown |
HY-114400 |
TRPV4 agonist-1 free base |
Agonist |
99.58% |
Unkown |
HY-101015A |
OBAA |
|
99.27% |
Unkown |
HY-108593 |
BMS-191011 |
Activator |
98.83% |
Unkown |
HY-13103 |
NS 11021 |
Activator |
99.51% |
Unkown |
HY-149662 |
TMDJ-035 |
Inhibitor |
99.44% |
Unkown |
HY-P1366 |
des-Gln14-Ghrelin |
|
98.61% |
Unkown |
HY-W194810 |
MCU-i11 |
|
98.42% |
Unkown |
HY-101396 |
ICA-069673 |
Activator |
99.65% |
Unkown |
HY-16639 |
ML314 |
Agonist |
99.52% |
Unkown |
HY-N7690 |
3,5,7,3′,4′-Pentamethoxyflavone |
Inhibitor |
99.15% |
Unkown |
HY-P0190A |
Iberiotoxin TFA |
Inhibitor |
99.67% |
Unkown |
HY-P1845A |
PACAP-38 (31-38), human, mouse, rat TFA |
Inducer |
98.33% |
Unkown |
HY-W131725 |
(+)-Norfenfluramine |
Agonist |
/ |
Unkown |
HY-103316A |
Ned 19 |
Inhibitor |
99.92% |
Unkown |
HY-108607 |
PACOCF3 |
Inhibitor |
≥98.0% |
Unkown |
HY-118010A |
(+)-Norfenfluramine hydrochloride |
Agonist |
99.77% |
Unkown |
HY-P0190 |
Iberiotoxin |
Inhibitor |
98.63% |
Unkown |
HY-P1845 |
PACAP-38 (31-38), human, mouse, rat |
Inducer |
99.98% |
Unkown |
HY-W001538 |
S-Propargylcysteine |
|
≥97.0% |
Unkown |
HY-W019981C |
Magnesium chloride hexahydrate, for cell culture |
Activator |
/ |
Unkown |
HY-12949A |
ML204 hydrochloride |
Inhibitor |
99.70% |
Unkown |
HY-12504 |
Pyr6 |
Inhibitor |
98.47% |
Unkown |
HY-12927 |
SX-517 |
Antagonist |
99.88% |
Unkown |
HY-136909 |
SR33805 |
Antagonist |
99.19% |
Unkown |
HY-162501 |
Yaddle1 |
Agonist |
99.14% |
Unkown |
HY-N7063 |
Nerol |
|
98.97% |
Unkown |
HY-P0256A |
Apamin TFA |
Inhibitor |
98.35% |
Unkown |
HY-135746 |
OR-1896 |
|
99.03% |
Unkown |
HY-136460 |
Calcium ionophore I |
|
≥99.0% |
Unkown |
HY-15292 |
S107 |
|
99.77% |
Unkown |
HY-15724A |
Vercirnon sodium |
Antagonist |
99.13% |
Unkown |
HY-P1076A |
CALP2 TFA |
Antagonist |
99.79% |
Unkown |
HY-P1077A |
CALP1 TFA |
|
98.30% |
Unkown |
HY-P3965 |
16-38-Thymosin β4 (cattle) |
Activator |
98.14% |
Unkown |
HY-157453 |
CCR4 antagonist 4 |
Antagonist |
99.72% |
Unkown |
HY-12498 |
GV-58 |
Agonist |
99.22% |
Unkown |
HY-137175 |
TMBIM6 antagonist-1 |
Antagonist |
99.60% |
Unkown |
HY-101329 |
Anthracene-9-carboxylic acid |
Inhibitor |
99.09% |
Unkown |
HY-103277A |
BIM 23042 TFA |
Antagonist |
96.20% |
Unkown |
HY-10388 |
TTA-Q6 |
Antagonist |
99.97% |
Unkown |
HY-125703 |
Ferutinin |
|
≥99.0% |
Unkown |
HY-129440 |
N-(p-Coumaroyl) Serotonin |
Inhibitor |
99.03% |
Unkown |
HY-135891 |
AZD2423 |
Antagonist |
99.91% |
Unkown |
HY-136190 |
TRPC6-PAM-C20 |
Agonist |
99.90% |
Unkown |
HY-N2500 |
Deoxypodophyllotoxin |
|
99.87% |
Unkown |
HY-W181102 |
NFAT Inhibitor-2 |
Inhibitor |
98.02% |
Unkown |
HY-41076 |
Ca2+ channel agonist 1 |
|
99.71% |
Unkown |
HY-100783 |
(-)-Bicuculline methobromide |
Antagonist |
≥99.0% |
Unkown |
HY-106844A |
(+)-EMD 57033 |
|
99.72% |
Unkown |
HY-108592 |
UCL 2077 |
Inhibitor |
98.91% |
Unkown |
HY-116291 |
4α-Phorbol 12,13-didecanoate |
Agonist |
99.30% |
Unkown |
HY-136409 |
N-Decanoyl-L-homoserine lactone |
|
99.43% |
Unkown |
HY-162426 |
UNC-CA2-103 |
|
99.26% |
Unkown |
HY-D1024A |
Coelenterazine h hydrochloride |
|
98.80% |
Unkown |
HY-P0271A |
Syntide 2 TFA |
|
98.26% |
Unkown |
HY-P4160 |
PDC31 |
Inhibitor |
99.76% |
Unkown |
HY-15084B |
Dizocilpine |
Antagonist |
99.90% |
Unkown |
HY-104058 |
Oregon-BAPTA Green 1AM |
|
92.0% |
Unkown |
HY-107855S |
DL-Mevalonolactone-d7 |
|
≥99.0% |
Unkown |
HY-108464A |
Phenamil methanesulfonate |
Inhibitor |
≥98.0% |
Unkown |
HY-108608 |
o-3M3FBS |
|
99.88% |
Unkown |
HY-120026 |
KB130015 |
Inhibitor |
98.28% |
Unkown |
HY-136182 |
YM-244769 dihydrochloride |
Inhibitor |
99.02% |
Unkown |
HY-A0236A |
Aprindine hydrochloride |
Inhibitor |
98.96% |
Unkown |
HY-D0202 |
Arsenazo III |
|
≥95.0% |
Unkown |
HY-E70200 |
Recombinant Kex2 protease |
|
/ |
Unkown |
HY-N0385 |
Gomisin J |
Activator |
99.84% |
Unkown |
HY-N2060 |
Evocarpine |
|
99.73% |
Unkown |
HY-W111226 |
Fmoc-His(3-Me)-OH |
Inhibitor |
≥98.0% |
Unkown |
HY-101366 |
A-61603 |
Agonist |
≥99.0% |
Unkown |
HY-103308 |
TRAM-39 |
Inhibitor |
99.66% |
Unkown |
HY-103317 |
NAADP |
|
95.8% |
Unkown |
HY-103442 |
CGP52411 |
Inhibitor |
99.82% |
Unkown |
HY-128678 |
ORM-10103 |
Inhibitor |
99.97% |
Unkown |
HY-13338 |
Mabuterol |
Agonist |
99.96% |
Unkown |
HY-136182A |
YM-244769 |
Inhibitor |
98.04% |
Unkown |
HY-146268 |
CaMKIIα-IN-1 |
Inhibitor |
98.41% |
Unkown |
HY-D0110A |
Fura-2 pentapotassium |
|
≥97.0% |
Unkown |
HY-N0081 |
(±)-Praeruptorin A |
Inhibitor |
99.94% |
Unkown |
HY-P1247 |
Calcineurin autoinhibitory peptide |
Inhibitor |
99.96% |
Unkown |
HY-P1250 |
RFRP-3(human) |
Agonist |
99.21% |
Unkown |
HY-P1479A |
Calmodulin-Dependent Protein Kinase II(290-309) acetate |
|
98.45% |
Unkown |
HY-P5914A |
Wasabi Receptor Toxin TFA |
Activator |
99.49% |
Unkown |
HY-W010451 |
1,2,4-Trihydroxybenzene |
Activator |
99.12% |
Unkown |
HY-101428 |
NS-638 |
Inhibitor |
99.84% |
Unkown |
HY-101693A |
Senazodan hydrochloride |
Inhibitor |
99.84% |
Unkown |
HY-103320B |
(1R,2R)-Calhex 231 hydrochloride |
|
99.07% |
Unkown |
HY-108496S |
Sphingosine-1-phosphate-d7 |
Agonist |
≥99.0% |
Unkown |
HY-11000A |
CaMKP inhibitor sodium |
Inhibitor |
98.06% |
Unkown |
HY-120597 |
SAK3 |
Activator |
≥99.0% |
Unkown |
HY-121604 |
(Rac)-MEM 1003 |
Inhibitor |
99.64% |
Unkown |
HY-13699 |
NBI-42902 |
|
98.65% |
Unkown |
HY-137790 |
Bicuculline methochloride |
Antagonist |
99.35% |
Unkown |
HY-147301A |
Resomelagon acetate |
Agonist |
99.75% |
Unkown |
HY-155516 |
KV1.3-IN-1 |
Inhibitor |
98.34% |
Unkown |
HY-15705 |
GPR35 agonist 2 |
|
98.84% |
Unkown |
HY-B0493S1 |
Niflumic acid-13C6 |
Inhibitor |
99.8% |
Unkown |
HY-D0121A |
INDO 1 pentapotassium |
|
≥95.0% |
Unkown |
HY-N0215S14 |
L-Phenylalanine-15N,d8 |
Antagonist |
99.90% |
Unkown |
HY-N0252A |
Catharanthine Tartrate |
Inhibitor |
98.88% |
Unkown |
HY-N1940 |
β-Anhydroicaritin |
Inhibitor |
99.09% |
Unkown |
HY-P1075 |
CALP3 |
Inhibitor |
98.57% |
Unkown |
HY-P1397A |
RVD-Hpα TFA |
Agonist |
99.32% |
Unkown |
HY-P5154A |
Tamapin TFA |
Antagonist |
98.79% |
Unkown |
HY-P5189A |
His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA |
|
99.31% |
Unkown |
HY-W013857 |
Lavendustin C |
Inhibitor |
98.32% |
Unkown |
HY-W041308 |
DCOIT |
Agonist |
99.74% |
Unkown |
HY-105118A |
Zaldaride maleate |
Antagonist |
≥98.0% |
Unkown |
HY-160023 |
D3S-001 |
Inhibitor |
/ |
Unkown |
HY-101902 |
Quin-2AM |
|
/ |
Unkown |
HY-100402 |
CFMTI |
Antagonist |
≥98.0% |
Unkown |
HY-100718 |
SCH00013 |
|
/ |
Unkown |
HY-101015 |
(2E)-OBAA |
|
/ |
Unkown |
HY-101329S |
Anthracene-9-carboxylic acid-d9 |
|
98.94% |
Unkown |
HY-103472 |
FPR-A14 |
Agonist |
99.90% |
Unkown |
HY-10388A |
TTA-Q6(isomer) |
|
99.84% |
Unkown |
HY-104056 |
Fura Red |
|
/ |
Unkown |
HY-107659 |
YM-244769 hydrochloride |
Inhibitor |
99.02% |
Unkown |
HY-107678 |
SEN12333 |
Agonist |
98.45% |
Unkown |
HY-113970A |
Nebracetam hydrochloride |
Agonist |
≥99.0% |
Unkown |
HY-115745 |
Calmodulin antagonist-1 |
Antagonist |
≥98.0% |
Unkown |
HY-117073 |
ITH12575 |
Inhibitor |
99.14% |
Unkown |
HY-119282 |
AZD6538 |
Inhibitor |
/ |
Unkown |
HY-120514 |
JNc-440 |
|
98.04% |
Unkown |
HY-120528 |
GB-110 |
Agonist |
/ |
Unkown |
HY-12550 |
GW542573X |
Activator |
98.79% |
Unkown |
HY-126583 |
Nemadipine-A |
Inhibitor |
98.0% |
Unkown |
HY-126789 |
DM-Nitrophen |
|
/ |
Unkown |
HY-129496 |
NP-313 |
Inhibitor |
99.58% |
Unkown |
HY-131040 |
NLRP3-IN-NBC6 |
Inhibitor |
99.40% |
Unkown |
HY-136395 |
Cartap |
Inducer |
/ |
Unkown |
HY-145384 |
ROC-0929 |
Inhibitor |
99.48% |
Unkown |
HY-147005 |
piCRAC-1 |
Inhibitor |
98.24% |
Unkown |
HY-147384 |
CXL-1020 |
|
≥99.0% |
Unkown |
HY-15671A |
GKA50 quarterhydrate |
Activator |
≥98.0% |
Unkown |
HY-161104 |
Kv2.1-IN-1 |
Inhibitor |
98.64% |
Unkown |
HY-163796 |
GPR183-IN-2 |
Inhibitor |
99.90% |
Unkown |
HY-16489A |
Terodiline hydrochloride |
Antagonist |
99.78% |
Unkown |
HY-B1221S1 |
Flufenamic acid-13C6 |
|
/ |
Unkown |
HY-N0252B |
Catharanthine Sulfate |
Inhibitor |
/ |
Unkown |
HY-N10772 |
Albanin A |
Inhibitor |
97.67% |
Unkown |
HY-N1584C |
Halofuginone lactate |
|
/ |
Unkown |
HY-N2359 |
Chelerythrine |
|
/ |
Unkown |
HY-N4267 |
Yangambin |
Inhibitor |
98.27% |
Unkown |
HY-N6688 |
Verruculogen |
Inhibitor |
97.52% |
Unkown |
HY-N6701 |
Dihydrocytochalasin B |
|
94.86% |
Unkown |
HY-NP009 |
α-Lactalbumin |
|
100.00% |
Unkown |
HY-P0271 |
Syntide 2 |
|
/ |
Unkown |
HY-P1079 |
ω-Agatoxin TK |
Inhibitor |
≥99.0% |
Unkown |
HY-P1387 |
β-Amyloid (1-40) (rat) |
Inducer |
95.13% |
Unkown |
HY-P3037 |
Imperatoxin A |
Activator |
/ |
Unkown |
HY-P3278 |
Caloxin 2A1 |
Inhibitor |
99.82% |
Unkown |
HY-P3811A |
Autocamtide-3 acetate |
|
99.62% |
Unkown |
HY-P3965A |
16-38-Thymosin β4 (cattle) (TFA) |
Activator |
98.14% |
Unkown |
HY-P5914 |
Wasabi Receptor Toxin |
Activator |
/ |
Unkown |
HY-P5988 |
N-myristoyl-RKRTLRRL |
Inhibitor |
99.37% |
Unkown |
HY-100928 |
YS 035 hydrochloride |
Antagonist |
99.15% |
Unkown |
HY-101693 |
Senazodan |
Inhibitor |
/ |
Unkown |
HY-113040A |
(17R,18S)-Epoxyeicosatetraenoic acid |
Inhibitor |
≥93.0% |
Unkown |
HY-12962 |
NMDA-IN-1 |
Antagonist |
98.98% |
Unkown |
HY-131948 |
3-Chlorodiphenylamine |
Activator |
98.74% |
Unkown |
HY-150135B |
D-myo-Inositol 1,4,5-trisphosphate tripotassium |
Activator |
98.00% |
Unkown |
HY-N0742 |
Absinthin |
Agonist |
≥98.0% |
Unkown |
HY-N7491A |
Ent-(+)-Verticilide |
Inhibitor |
/ |
Unkown |
HY-P3037A |
Imperatoxin A TFA |
Activator |
98.65% |
Unkown |
HY-114400A |
TRPV4 agonist-1 |
Agonist |
/ |
Unkown |
HY-103309A |
ML218 hydrochloride |
Inhibitor |
/ |
Unkown |
HY-125836 |
CCR4 antagonist 2 |
Antagonist |
/ |
Unkown |
HY-145456 |
Gallium 8-Hydroxyquinolinate |
Inducer |
/ |
Unkown |
HY-19805A |
STO-609 acetate |
Inhibitor |
/ |
Unkown |
HY-N1584B |
Halofuginone hydrochloride |
|
/ |
Unkown |
HY-14656S |
Diltiazem-d3 hydrochloride |
Antagonist |
98.46% |
Unkown |
HY-B0632S |
Diltiazem-d6 |
Antagonist |
/ |
Unkown |
HY-P2471 |
Neurogranin (48-76), mouse |
Inhibitor |
/ |
Unkown |
HY-100783A |
(-)-Bicuculline methochloride |
Antagonist |
/ |
Unkown |
HY-100783B |
Bicuculline methobromide |
Antagonist |
/ |
Unkown |
HY-101685A |
Iganidipine di(hydrochloride) |
Antagonist |
/ |
Unkown |
HY-103277 |
BIM 23042 |
Antagonist |
/ |
Unkown |
HY-103309S |
ML218-d9 |
Inhibitor |
/ |
Unkown |
HY-103313 |
SR33805 oxalate |
Antagonist |
/ |
Unkown |
HY-103320 |
Calhex 231 |
Antagonist |
/ |
Unkown |
HY-103544 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P |
|
/ |
Unkown |
HY-105118 |
Zaldaride |
Inhibitor |
/ |
Unkown |
HY-106818A |
Monatepil maleate |
|
/ |
Unkown |
HY-106837 |
Israpafant |
Antagonist |
/ |
Unkown |
HY-107855S1 |
DL-Mevalonolactone-d3 |
|
/ |
Unkown |
HY-110140 |
(E)-KN-93 phosphate |
Inhibitor |
99.85% |
Unkown |
HY-110312 |
JTV-519 fumarate |
|
/ |
Unkown |
HY-111014 |
VK-II-36 |
Activator |
99.63% |
Unkown |
HY-111214 |
K-14585 |
|
/ |
Unkown |
HY-112741 |
SB-209247 |
Antagonist |
/ |
Unkown |
HY-113308AS |
Taurolithocholic acid-d4 sodium |
Agonist |
/ |
Unkown |
HY-113308AS1 |
Taurolithocholic Acid-d5 sodium salt |
Agonist |
/ |
Unkown |
HY-113308AS2 |
Taurolithocholic acid-d4-1 sodium |
Agonist |
/ |
Unkown |
HY-113920 |
Azumolene sodium |
Inhibitor |
/ |
Unkown |
HY-114691 |
R 59494 |
|
/ |
Unkown |
HY-114826 |
Prostaglandin E2-1-glyceryl ester |
Activator |
/ |
Unkown |
HY-115493 |
TIQ-15 |
Antagonist |
/ |
Unkown |
HY-115767 |
(±)-1,2-Diolein |
Activator |
/ |
Unkown |
HY-116153 |
HUHS2002 |
|
/ |
Unkown |
HY-116330 |
Hyperforin |
|
/ |
Unkown |
HY-116429A |
7(S)-Maresin 1 |
|
/ |
Unkown |
HY-116429S |
Maresin 1-d5 |
Inhibitor |
/ |
Unkown |
HY-116500A |
AH-1058 |
|
/ |
Unkown |
HY-117099 |
TMB-8 |
Antagonist |
/ |
Unkown |
HY-120699 |
RO5488608 |
Modulator |
/ |
Unkown |
HY-120820 |
LY320954 |
Antagonist |
/ |
Unkown |
HY-12153 |
JNJ-1930942 |
Modulator |
/ |
Unkown |
HY-12155 |
JNJ-26990990 |
Inhibitor |
/ |
Unkown |
HY-121584 |
Lycoperodine-1 |
Agonist |
99.82% |
Unkown |
HY-12542S |
Dantrolene-13C3 |
Inhibitor |
≥99.0% |
Unkown |
HY-12596 |
JNJ-26489112 |
|
/ |
Unkown |
HY-126789A |
DM-Nitrophen tertasodium |
|
/ |
Unkown |
HY-126821 |
Fluo-3 |
|
/ |
Unkown |
HY-126821A |
Fluo-3 pentaammonium |
|
/ |
Unkown |
HY-129088 |
HUP30 |
|
99.68% |
Unkown |
HY-129547 |
Fluo-3 pentapotassium |
|
/ |
Unkown |
HY-131001 |
DPNB-ABT594 |
Agonist |
/ |
Unkown |
HY-131012 |
GoSlo-SR-5-69 |
Activator |
/ |
Unkown |
HY-131041 |
Ned-K |
|
/ |
Unkown |
HY-131942 |
sFTX-3.3 |
Antagonist |
/ |
Unkown |
HY-132190 |
Hexanolamino PAF C-16 |
Antagonist |
/ |
Unkown |
HY-133596 |
12,14-Dichlorodehydroabietic acid |
|
/ |
Unkown |
HY-135110 |
Rp-8-Br-cGMPS sodium |
|
/ |
Unkown |
HY-135433 |
MAPTAM |
|
/ |
Unkown |
HY-135478 |
LY393615 |
Inhibitor |
/ |
Unkown |
HY-136189 |
UK-59811 hydrochloride |
Inhibitor |
/ |
Unkown |
HY-136283 |
DMNPE-4 AM-caged-calcium |
|
/ |
Unkown |
HY-136661 |
(-)-N6-Phenylisopropyl adenosine |
Agonist |
/ |
Unkown |
HY-136894 |
Rhod-5N |
|
/ |
Unkown |
HY-138951 |
AY77 |
Agonist |
/ |
Unkown |
HY-138990 |
GK563 |
Inhibitor |
/ |
Unkown |
HY-139041 |
Palmitoylcholine chloride |
|
/ |
Unkown |
HY-142050 |
(R)-IDHP |
|
/ |
Unkown |
HY-142087 |
Beauverolide Ja |
Inhibitor |
/ |
Unkown |
HY-145196 |
RTICBM-189 |
Modulator |
99.73% |
Unkown |
HY-145385 |
Coelenteramide |
|
/ |
Unkown |
HY-145900 |
S100A2-p53-IN-1 |
Inhibitor |
/ |
Unkown |
HY-146232 |
F 13714 |
Agonist |
/ |
Unkown |
HY-146461 |
Anticancer agent 58 |
|
/ |
Unkown |
HY-146462 |
Anticancer agent 59 |
|
/ |
Unkown |
HY-14656S1 |
Diltiazem-(acetoxy-d3) (hydrochloride) |
Antagonist |
/ |
Unkown |
HY-147186 |
5,5'-Difluoro BAPTA |
|
/ |
Unkown |
HY-147377 |
N-Salicyloyltryptamine |
|
96.37% |
Unkown |
HY-147383 |
NS-8 |
Activator |
/ |
Unkown |
HY-149483 |
CVN417 |
Antagonist |
/ |
Unkown |
HY-150039 |
CCG-271423 |
Inhibitor |
/ |
Unkown |
HY-15018A |
SSR126768A free base |
Antagonist |
/ |
Unkown |
HY-151451 |
Cav 3.2 inhibitor 2 |
Inhibitor |
/ |
Unkown |
HY-151452 |
Cav 3.2 inhibitor 3 |
Inhibitor |
/ |
Unkown |
HY-151547 |
MRS4719 |
Antagonist |
/ |
Unkown |
HY-15293 |
JTV-519 |
Inhibitor |
/ |
Unkown |
HY-156082 |
RyRs activator 3 |
Inhibitor |
/ |
Unkown |
HY-156104 |
CaMKIIα-PHOTAC |
Degrader |
/ |
Unkown |
HY-158779 |
Sulfane sulfur probe 4 |
|
/ |
Unkown |
HY-160998 |
YM-344031 |
Antagonist |
/ |
Unkown |
HY-161388 |
NSCLC-IN-1 |
Inducer |
/ |
Unkown |
HY-162280 |
PROTAC BTK Degrader-9 |
|
/ |
Unkown |
HY-162374 |
ANO61 |
Inhibitor |
/ |
Unkown |
HY-162375 |
AF299 |
|
/ |
Unkown |
HY-162774A |
GRP75-IN-1 hydrochloride |
Inducer |
/ |
Unkown |
HY-163795 |
GPR183-IN-1 |
Inhibitor |
/ |
Unkown |
HY-164684 |
Dichlorobenzamil |
Inhibitor |
/ |
Unkown |
HY-169115A |
(Rac)-PD0299685 |
|
/ |
Unkown |
HY-169332 |
Piezo1 agonist 1-d2 |
|
/ |
Unkown |
HY-17404S |
Cilnidipine-d7 |
Inhibitor |
/ |
Unkown |
HY-19025 |
CV-159 |
Antagonist |
/ |
Unkown |
HY-19409 |
AJG049 |
Antagonist |
/ |
Unkown |
HY-19857 |
Sulcardine sulfate |
|
/ |
Unkown |
HY-A0057AS2 |
Gabapentin-d4 hydrochloride |
Inhibitor |
/ |
Unkown |
HY-B0358AS |
Flunarizine-d8 dihydrochloride |
|
/ |
Unkown |
HY-B0596S |
Taltirelin-13C,d3 |
|
/ |
Unkown |
HY-B1221S |
Flufenamic acid-d4 |
|
/ |
Unkown |
HY-B1726 |
Phenacaine |
Inhibitor |
/ |
Unkown |
HY-B1837A |
β-Cyfluthrin |
Inhibitor |
99.94% |
Unkown |
HY-B1837AR |
β-Cyfluthrin (Standard) |
Inhibitor |
/ |
Unkown |
HY-D0121 |
INDO 1 |
|
/ |
Unkown |
HY-D0157 |
ZnAF-2 |
|
/ |
Unkown |
HY-D0861A |
EGTA tetrasodium |
|
/ |
Unkown |
HY-D1424 |
Coelenterazine hcp |
|
/ |
Unkown |
HY-D1501 |
Fura PE-3 potassium |
|
/ |
Unkown |
HY-D1608 |
BODIPY FL Thapsigargin |
Inhibitor |
/ |
Unkown |
HY-D1631 |
Calcium Green-5N AM |
|
/ |
Unkown |
HY-D1636 |
5-Nitro BAPTA |
|
/ |
Unkown |
HY-D1640 |
5',5-Difluoro BAPTA tetrapotassium |
|
/ |
Unkown |
HY-D1643 |
5,5'-Dinitro BAPTA AM |
|
/ |
Unkown |
HY-D1700 |
Mag-indo-1/AM |
|
/ |
Unkown |
HY-D1702 |
Mag-Fura-2 tetrapotassium |
|
/ |
Unkown |
HY-D1755 |
Fluo-3FF AM |
|
/ |
Unkown |
HY-E70197 |
Calpain-1 (pig) |
|
/ |
Unkown |
HY-E70197A |
Calpain-1, Human Erythrocyte |
Modulator |
/ |
Unkown |
HY-N0081A |
(-)-Praeruptorin A |
Inhibitor |
/ |
Unkown |
HY-N10512 |
Gangliotetraose |
|
/ |
Unkown |
HY-N10754 |
Aschantin |
Inhibitor |
/ |
Unkown |
HY-N11887 |
Linocinnamarin |
Inhibitor |
/ |
Unkown |
HY-N1228 |
Soyacerebroside I |
|
/ |
Unkown |
HY-N3729 |
(-)-Denudatin B |
Inhibitor |
≥97.0% |
Unkown |
HY-N4237 |
Saikogenin D |
|
98.95% |
Unkown |
HY-N5123 |
α-L-Rhamnose |
|
/ |
Unkown |
HY-N7063R |
Nerol (Standard) |
|
/ |
Unkown |
HY-N7594 |
Senecionine acetate |
|
/ |
Unkown |
HY-N7875 |
Celangulin |
|
/ |
Unkown |
HY-N9404 |
6-Benzoylheteratisine |
Inhibitor |
99.66% |
Unkown |
HY-P10316 |
CaMKI(299-320) |
Modulator |
/ |
Unkown |
HY-P10328 |
Vasoactive intestinal contractor |
Inhibitor |
/ |
Unkown |
HY-P10655 |
Caloxin 1C2 |
Inhibitor |
/ |
Unkown |
HY-P1075A |
CALP3 TFA |
Inhibitor |
/ |
Unkown |
HY-P1076 |
CALP2 |
Antagonist |
/ |
Unkown |
HY-P1077 |
CALP1 |
|
/ |
Unkown |
HY-P1080 |
ω-Agatoxin IVA |
Inhibitor |
/ |
Unkown |
HY-P1247A |
Calcineurin autoinhibitory peptide TFA |
Inhibitor |
/ |
Unkown |
HY-P1250A |
RFRP-3(human) TFA |
Agonist |
/ |
Unkown |
HY-P1345 |
TLQP-21 |
Agonist |
/ |
Unkown |
HY-P1366A |
des-Gln14-Ghrelin TFA |
|
/ |
Unkown |
HY-P1437A |
Neuropeptide S(Mouse) TFA |
Agonist |
/ |
Unkown |
HY-P1479 |
Calmodulin-Dependent Protein Kinase II (290-309) |
|
/ |
Unkown |
HY-P1640 |
(Trp63,Trp64)-C3a(63-77) |
Agonist |
/ |
Unkown |
HY-P1805 |
Calmodulin Binding Peptide 1 |
Inhibitor |
/ |
Unkown |
HY-P1821 |
Myelin Basic Protein |
|
/ |
Unkown |
HY-P2847 |
Urocortin II, mouse |
Inhibitor |
/ |
Unkown |
HY-P3156 |
Syringomycin E |
Inhibitor |
/ |
Unkown |
HY-P3316 |
OSK-1 |
Inhibitor |
/ |
Unkown |
HY-P3811 |
Autocamtide-3 |
|
/ |
Unkown |
HY-P3943 |
Calmodulin Dependent Protein Kinase Substrate Analog |
|
/ |
Unkown |
HY-P3944 |
Calmodulin Dependent Protein Kinase Substrate |
|
/ |
Unkown |
HY-P5154 |
Tamapin |
Antagonist |
/ |
Unkown |
HY-P5422 |
Caloxin 3A1 |
Inhibitor |
/ |
Unkown |
HY-P5796 |
FS-2 |
Inhibitor |
/ |
Unkown |
HY-P5869 |
Kurtoxin |
|
/ |
Unkown |
HY-P5870 |
KTX-Sp2 |
Inhibitor |
/ |
Unkown |
HY-P6008 |
Myoregulin |
|
/ |
Unkown |
HY-P6008A |
Myoregulin TFA |
|
/ |
Unkown |
HY-P6013 |
wt hMLN |
Inhibitor |
/ |
Unkown |
HY-Q40876 |
BBT |
Modulator |
99.71% |
Unkown |
HY-RS01768 |
CA2 Human Pre-designed siRNA Set A |
Pre-designed Sets |
/ |
Unkown |
HY-U00026 |
Semotiadil recemate fumarate |
|
/ |
Unkown |
HY-W040028 |
Cartap hydrochloride |
Inducer |
/ |
Unkown |
HY-W748509 |
Pipernonaline |
|
/ |
Unkown |
HY-W755295 |
Mabuterol hydrochloride |
Agonist |
/ |
Unkown |
HY-100981 |
MR-16728 hydrochloride |
|
/ |
Unkown |
HY-101669 |
TDN345 |
Antagonist |
/ |
Unkown |
HY-10167 |
Tecalcet |
Modulator |
/ |
Unkown |
HY-101685 |
Iganidipine |
Antagonist |
/ |
Unkown |
HY-10341D |
Fasudil mesylate |
|
/ |
Unkown |
HY-108984 |
BBMP |
|
/ |
Unkown |
HY-111198 |
YM-355179 fumarate |
|
/ |
Unkown |
HY-111527 |
PPZ2 |
|
/ |
Unkown |
HY-113723 |
MRS2298 |
Antagonist |
/ |
Unkown |
HY-114743 |
GS 283 |
|
/ |
Unkown |
HY-115231 |
ci-IP3/PM |
|
/ |
Unkown |
HY-116072 |
Antiarrhythmic agent-2 |
Inhibitor |
/ |
Unkown |
HY-116723 |
CFMMC |
Antagonist |
/ |
Unkown |
HY-117055 |
Ro 18-3981 |
Inhibitor |
/ |
Unkown |
HY-117982 |
SKI2496 |
|
/ |
Unkown |
HY-120985 |
Araguspongin B |
|
/ |
Unkown |
HY-121366 |
Kadethrin |
Inhibitor |
/ |
Unkown |
HY-121516 |
CM-TPMF |
|
/ |
Unkown |
HY-121914 |
(2-Chlorophenyl)diphenylmethanol |
Inhibitor |
/ |
Unkown |
HY-130358 |
PDDHV |
Activator |
/ |
Unkown |
HY-131764 |
2'-O-MB-cGMP sodium |
Inhibitor |
/ |
Unkown |
HY-133614 |
Dihydroisopimaric acid |
Activator |
/ |
Unkown |
HY-135110A |
Rp-8-Br-cGMPS |
|
/ |
Unkown |
HY-135478A |
LY393615 free base |
Inhibitor |
/ |
Unkown |
HY-137172 |
ETH 157 |
|
/ |
Unkown |
HY-147301B |
Resomelagon methanesulfonate |
Agonist |
/ |
Unkown |
HY-149779 |
RyR2 stabilizer-1 |
Modulator |
/ |
Unkown |
HY-154924 |
Thio-NADP |
|
/ |
Unkown |
HY-164682 |
AMD 3329 octahydrobromide |
|
/ |
Unkown |
HY-167091 |
Beraprost |
|
/ |
Unkown |
HY-167203 |
AJG049 free base |
Antagonist |
/ |
Unkown |
HY-19044 |
SKF 95601 |
|
/ |
Unkown |
HY-19062 |
SM-6586 |
|
/ |
Unkown |
HY-I0466 |
Glutarimide |
|
97.00% |
Unkown |
HY-N7364S |
(E)-β-Farnesene-d6 |
Inhibitor |
/ |
Unkown |
HY-N7436S |
Methyl propyl disulfide-d3 |
|
/ |
Unkown |
HY-W150752 |
Triphenylethylene |
|
/ |
Unkown |
HY-132191 |
Pradimicin A |
Inhibitor |
/ |
Unkown |
HY-U00354 |
CP-060 |
Antagonist |
/ |
Unkown |